HCMV: Pathogenesis and disease consequences

Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis

Volumn , Issue , 2007, Pages 737-764

  Britt, William ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61349126074     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511545313.042     Document Type: Chapter

References (333)

1. Achim, C. L., Nagra, R. M. Wang, R., Nelson, J. A., and Wiley, C. A. (1994). Detection of cytomegalovirus in cerebrospinal fluid autopsy specimens from AIDS patients. J. Infect. Dis., 169, 623-627.
2. Adler, S. P. (1983). Transfusion-associated cytomegalovirus infec-tions. Rev. Infect. Dis., 5, 977-993.
3. Adler, S. P. (1985). The molecular epidemiology of cytomegalovirus transmission among children attending a day care center. J. Infect. Dis., 152, 760-768.
4. Adler, S. P. (1988a). Cytomegalovirus transmission among children in day care, their mothers and caretakers. Pediatr. Infect. Dis. J., 7, 279-285.
5. Adler, S. P. (1988b). Molecular epidemiology of cytomegalovirus: Viral transmission among children attending a day care center, their parents, and caretakers. J. Pediatr., 112, 366-372.
6. Adler, S. P. (1989). Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. N. Engl. J. Med., 321, 1290-1296.
7. Adler, S. P. (1991a). Cytomegalovirus and child day care: Risk factors for maternal infection. Pediatr. Infect. Dis. J., 10, 590.
8. Adler, S. P. (1991b). Molecular epidemiology of cytomegalovirus: A study of factors affecting transmission among children at three day-care centers. Pediatr. Infect. Dis. J., 10, 584-590.
9. Adler, S. P., Chandrika, T., Lawrence, L., and Baggett, J. (1983). Cytomegalovirus infections in neonates due to blood trans-fusions. Pediatr. Infect. Dis., 2, 114-118.
10. Adler, S. P., Baggett, J., Wilson, M., Lawrence L., and McVoy, M. (1986). Molecular epidemiology of cytomegalovirus in a nursery: Lack of evidence for nosocomial transmission. J. Pedi-atr., 108, 117-123.
11. Adler, S. P., Starr, S. E., Plotkin, S. A. et al. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis., 171, 26-32.
12. Ahlfors, K. and Ivarsson, S. A. (1985). Cytomegalovirus in breast milk of Swedish milk donors. Scand. J. Infect. Dis., 17, 11.
13. Aldrete, J. S., Sterlin, W. A., Hathway, B. M., Morgan, J. M., and Diethelm. A. G. (1975). Gastrointestinal and hepatic compli-cations affecting patients with renal allografts. Am. J. Surg., 129, 115-124.
14. Alford, C. A., Stagno, S., Pass, R. F., and Huang, E. S. (1981). Epi-demiology of cytomegalovirus. In The Human Herpesviruses: An Interdisciplinary Perspective, ed A. Nahmais, W. Dowdle, and R. Schinazi, pp. 159-171. New York: Elsevier.
15. Arribas, J. R., Storch, G. A., Clifford, D. B., and Tselis, A. C., (1996). Cytomegalovirus encephalitis. Ann. Int. Med., 125, 577-587.
16. Armstrong, J. A., Tarr, G. C., Youngblood, L. A. et al. (1976). Cytomegalovirus infection in children undergoing open heart surgery. Yale. J. Biol. Med., 49, 83-91.
17. Asanuma, H., Numazaki, K., Nagata, N., Hotsubo, T., Horino, K., and Chiba, S. (1996). Role of milk whey in the transmission of human cytomegalovirus infection by breast milk. Microbiol. Immunol., 40, 201-204.
18. Baldanti, F., Revello, M. G., Percivalle, E., and Gerna, G. (1998). Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. J. Clin. Virol., 11, 51-60.
19. Bale, J. F. (1984). Human cytomegalovirus infection and disorders of the nervous system. Arch. Neurol., 41, 310-320.
20. Bale, J. F., Jr. and O'Neil, M. E. (1989). Detection of murine cytomegalovirus DNA in circulating leukocytes harvested dur-ing acute infection of mice.[erratum appears in J. Virol. 1989 Sep;63(9):4120]. J. Virol., 63, 2667-2673.
21. Bale, J. F., Jr., O'Neil, M. E., Hart, M. N., Harris, J. D., and Stin-ski M.F. (1989). Human cytomegalovirus nucleic acids in tis-sues from congenitally infected infants. Pediatr. Neurol. 5, 216-220.
22. Bale, J. F., Jr., Petheram, S. J., Souza, I. E., and Murph, J. R. (1996). Cytomegalovirus reinfection in young children. J. Pediatr. 128, 347-352.
23. Balfour, C. L. and Balfour, H. H. (1986). Cytomegalovirus is not an occupational risk for nurses in renal transplant and neonatal units. J.Am.Med. Assoc., 256, 1909-1914.
24. Balthesen, M., Messerle, M., and Reddehase, M. J. (1993). Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol., 67, 5360-5366.
25. Barry, S. M., Johnson, M. A., and Janossy, G. (2000). Cytopathology or immunopathology The puzzle of cytomegalovirus pneu-monitis revisited. Bone Marrow Transpl. 26, 591-597.
26. Becroft, D. M. O. (1981). Prenatal cytomegalovirus infection: Epi-demiology, pathology, and pathogenesis. In Perspective in Pediatric Pathology, vol. 6, ed. H. S. Rosenberg and J. Bern-stein, pp. 203-241. New York; Masson Press.
27. Beisser, P. S., Goh, C. S., Cohen, F. E., and Michelson, S.(2002). Viral chemokine receptors and chemokines in human cytomegalovirus traficking and interaction with the immune system. CMV chemokine receptors. Curr Top. Microbiol. Immunol., 269, 203-234.
28. Bernstein, D. I. and Bourne, N. (1999). Animal models for cytomegalovirus infection: Guinea-pig CMV. In Handbook of Animal Models of Infection, ed. M. S. O. Zak. London: Academic Press.
29. Billstrom Schroeder, M. and Worthen, G. S. (2001). Viral regulation of RANTES expression during human cytomegalovirus infec-tion of endothelial cells. J. Virol., 75, 3383-3390.
30. Billstrom Schroeder, M., Christensen, R., and Worthen, G. S. (2002). Human cytomegalovirus protects endothelial cells from apop-tosis induced by growth factor withdrawal. J. Clini. Virol., 25, S149-S157.
31. Blaser, M. J. and Cohn D. L. (1986). Opportunistic infections in patients with AIDS: Clues to the epidemiology of AIDS and the relative virulence of pathogens. Rev. Infect. Dis., 8, 21-30.
32. Bodaghi, B., Jones, T. R., Zipeto, D. et al. (1998). Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J. Exp. Medi. 188, 855-866.
33. Boeckh, M. and Boivin, G. (1998). Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin. Micro-biol. Rev. 11, 533-554.
34. Boeckh, M. and Bowden, R. (1995). Cytomegalovirus infection in marrow transplantation. In C. D. Buckner (ed.), Technical and Biological Components of Marrow Transplantation, ed. C. D. Buckner, pp. 97-136. Boston: Kluwer Academic Publishers.
35. Boeckh, M., Gooley, T. A., Myerson, D., Cunningham, T., Schoch, G., and Bowden, R. A., (1996). Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study. Blood, 88, 4063-4071.
36. Boeckh, M., Gallez-Hawkins, G. M., Myerson, D., Zaia, J. A., and Bowden R. A. (1997). Plasma polymerase chain reac-tion for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation, 64, 108-113.
37. Boeckh, M., Leisenring, W., Riddell, S. R. et al. (2003). Late cytomegalovirus disease and mortality in recipients of allo-geneic hematopoietic stem cell transplants: Importance of viral load and T-cell immunity. Blood, 101, 407-414.
38. Bolovan-Fritts, C. and Wiedeman, J. A. (2001). Human cytomegalovirus strain Toledo lacks a virus-encoded tropism factor required for infection of aortic endothelial cells. J. Infect. Dis., 184, 1252-1261.
39. Boppana, S. B., Rivera, L. B., Fowler, K. B., Mach, M., and Britt W. J. (2001a). Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Medi., 344, 1366-1371.
40. Boppana, S. B., Rivera, L. B., Fowler, K. B., Yang, J., and Britt, W. J. (2001b). Presented at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, Decem-ber 16-19.
41. Borisch, B., Jahn, G., Scholl, B. C. et al. (1988). Detection of human cytomegalovirus DNA and viral antigens in tissues of different manifestations of CMV infections. Virch. Arch.[B], 55, 93-99.
42. Bowden, R. A. (1995). Transfusion-transmitted cytomegalovirus infection. Hematol.-Oncol. Clini. N. Am. 9, 155-166.
43. Bowden, R. A., Slichter, S. J., Sayers, M. H., Mori, M., Cays, M. J., and Meyers, J. D. (1991). Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood, 78, 246-250.
44. Bowen, E. F., Wilson, P., Atkins, M., et al. (1995). Natural history of untreated cytomegalovirus retinitis. Lancet, 346, 1671-1673.
45. Bowen, E. F., Wilson, P., Cope, A. et al. (1996). Cytomegalovirus retinitis in AIDS patients: Influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 10, 1515-1520.
46. Brady, M. T., Milam, J. D. Anderson, D.C. et al. (1984). Use of deg-lycerolized red blood cells to prevent posttransfusion infection with cytomegalovirus in neonates. J. Infect. Dis., 150, 334-339.
47. Brody, A. R. and Craighead, J. E. (1974). Pathogenesis of pulmonary cytomegalovirus infection in immunosuppressed mice. J Infect. Dis., 129, 677.
48. Browne, E. P., Wing, B., Coleman, D., and Shenk, T., (2001a). Altered cellular mRNA levels in human cytomegalovirus-infected broblasts: Viral block to the accumulation of antiviral mRNAs. J. Virol., 75, 12319-12330.
49. Browne, G., Whitworth, C., Bellamy, C., and Ogilvie, M.M. (2001b). Acute allograft glomerulopathy associated with CMV viraemia. Nephrol. Dial. Transpl., 16, 861-862.
50. Brune, W., Hasan, M., Krych, M., Bubic, I., Jonjic, S., and Koszi-nowski U. H. (2001a). Secreted virus-encoded proteins reject murine cytomegalovirus productivity in organs. J. Infect. Dis. 184, 1320-1324.
51. Brune, W., Menard, C. Heesemann, J., and Koszinowski, U. H. (2001b). A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. Science, 291, 303-305.
52. Burns, L. J., Pooley, J. C., Walsh D. J., Vercellotti, G. M., Weber, M. L., and Kovacs A. (1999). Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins. Transplantation, 67, 137-144.
53. CDC (1985). Prevalence of cytomegalovirus excretion from children in five day care centers-Alabama. Morb. Mortal. Wkly Rep., 34, 49-51.
54. Cha, T., Tom, E. Kembel, G. W., Duke, G. M., Mocarski, E. S., and Spaete, R. R. (1996). Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70, 78-83.
55. Chandler, S. H., Holmes, K. K., Wentworth, B. B. et al. (1985). The epidemiology of cytomegaloviral infection in women attend-ing a sexually transmitted disease clinic. J. Infect. Dis., 152, 597-605.
56. Chandler, S. H., Handsfield, H. H., and McDougally, J. K. (1987). Isolation of multiple strains of cytomegalovirus from women attending a clinic for sexually transmitted disease. J. Infect. Dis. 155, 655-660.
57. Chern, K. C., Chandler, D. B., Martin, D. F., Kuppermann, B. D., Wolitz, R. A., and Margolis, T. P. (1998). Glycoprotein B subtyp-ing of cytomegalovirus (CMV) in the vitreous of patients with AIDS and CMV retinitis. J. Infect. Dis., 178, 1149-1153.
58. Chou, S. W. (1986). Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N. Engl. J. Med., 314, 1418-1423.
59. Cinatl, J., Jr., Cinatl, J., Vogel, J. U., Rabenau, H., Kornhuber, B., and Doerr, H. W. (1996). Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology, 39, 259-269.
60. Cobbs, C. S., Harkins, L., Samanta, M. et al. (2002). Human cytomegalovirus infection and expression in human malig-nant glioma. Cancer Res., 62, 3347-3350.
61. Cole, R. and Kuttner, A. G. (1926). A filtrable virus present in the submaxillary glands of guinea pigs. J. Exp. Med. 44, 855-873.
62. Collier, A. C., Handsfield, H. H., Roberts, P. L. et al. (1990). Cytomegalovirus infection in women attending a sexually transmitted disease clinic. J. Infect. Dis., 162, 46-51.
63. Collier, A. C., Handsfield, H. H., Ashley R. et al. (1995). Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J. Infect. Dis., 171, 33-38.
64. Collins, T. M., Quirk, M. R., and Jordan, M. C. (1994). Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J. Virol., 68, 6305-6311.
65. Compton, T., Kurt-Jones, E. A. Bochme, K. W. et al. (2003). Human cytomegalovirus activates infiammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol., 77, 4588-4596.
66. Coonrod, D., Collier, A. C., Ashley, R., DeRouen, T., and Corey, L. (1998). Association between cytomegalovirus seroconversion and upper genital tract infection among women attending a sexually transmitted disease clinic: A prospective study. J. Infect. Dis. 177, 1188-1193.
67. Cope, A. V., Sabin, C., Burroughs, A., Rolles, K., Griffiths, P. D., and Emery V. C. (1997). Interrelationships among quan-tity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methyl-prednisolone as risk factors for HCMV disease following liver transplantation. J. Infect. Dis., 176, 1484-1490.
68. Craigen, J. L., Yong, K. L., Jordan, N. J. et al. (1997). Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migra-tion. Immunology, 92, 138-145.
69. Davis-Poynter, N. J., Lynch, D. M., Vally, H. et al. (1997). Identi-fication and characterization of a G protein-coupled recep-tor homolog encoded by murine cytomegalovirus. J. Virol., 71, 1521-1529.
70. De La Melena, V. T., Kreklywich, C. N., Streblow, D. N. et al. (2001). Kinetics and development of CMV-accelerated transplant vas-cular sclerosis in rat cardiac allografts is linked to early increase in chemokine expression and presence of virus. Transpl. Proc 33, 1822-1823.
71. Demmler, G. J., Yow, M. D., Spector, S. A. et al. (1987). Nosoco-mial cytomegalovirus infections within two hospitals caring for infants and children. J. Infect. Dis., 156, 9-16.
72. Diamond, C., Speck, C., Huang, M. L., Corey, L., Coombs, R. W., and Krieger, J. N. (2000). Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men. J. Virol. Methods, 90, 185-191.
73. Dieterich, D. T. and Rahmin, M. (1991). Cytomegalovirus colitis in AIDS: Presentation in 44 patients and a review of the literature. J. AIDS, 4, S29-S35.
74. Dobbins, J. G., Adler, S. P., Pass, R. F., Bale, J. F., Grillner, L., and Stewart, J. A. (1993). The risks and benefits of cytomegalovirus transmission in child day care. Am. J. Publ. Hlth in press.
75. Drew, W. L.(1992). Cytomegalovirusinfectioninpatientswith AIDS. Clin. Infect. Dis., 14, 608-615.
76. Drew, W. L. and Mintz, L. (1984). Cytomegalovirus infection in healthy and immune-deficient homosexual men. In The Acquired Immune Deficiency Syndrome and Infections of Homosexual Men, ed. P. Ma and D. Armstrong, pp. 117-123. New York: Yorke Medical Books.
77. Drew, W. L., Mintz, L., Miner, R. C., Sands, M., and Ketterer, B.(1981). Prevalence of cytomegalovirus infection in homosexual men. J. Infect. Dis., 143, 188-192.
78. Drew, W. L., Sweet, E. S., Miner, R. C., and Mocarski, E. S.(1984). Mul-tiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: Documentation by Southern blot hybridization. J. Infect. Dis., 150, 952-953.
79. Drew, W. L., Tegtmeier, G., Alter, H. J., Laycock, M. E., Miner, R. C., and Busch, M. P. (2003). Frequency and duration of plasma CMV viremia in seroconverting blood donors and recipients.[comment]. Transfusion, 43, 309-313.
80. Dworsky, M., Welch, K., Cassady, G., and Stagno, S. (1983a). Occu-pational risk for primary cytomegalovirus infection among pediatric health care workers. N. Engl. J. Med., 309, 950-953.
81. Dworsky, M., Yow, M., Stagno, S., Pass, R. F., and Alford, C. (1983b). Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics, 72, 295-299.
82. Dworsky, M., Lakeman, A., and Stagno, S. (1984). Cytomegalovirus transmission within a family. Pediatr. Infect. Dis. 3, 236-238.
83. Emanuel, D., Cunningham, I., Jules-Elysee, K. et al. (1988). Cytomegalovirus pneumonia after bone marrow transplanta-tion successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann. Intern. Med., 109, 777-782.
84. Emery, V. C., Sabin, C. A., Cope, A. V., Gor, D., Hassan-Walker, A. F., and Griffiths, P. D. (2000). Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.[comment]. Lancet, 355, 2032-2036.
85. Epstein, S. E., Speir, E., Zhou, Y. F., Guetta, E., Leon, M., and Finkel, T. (1996). The role of infection in restenosis and atherosclerosis: Focus on cytomegalovirus. Lancet, 348, s13-s17.
86. Erice, A., Holm, M. A., Gill, P. C. et al. (1992). Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for apid detection of CMV in polymorphonuclear blood leuko-cytes. J. Clin. Microbiol., 30, 2822-2825.
87. Evans, P. C., Coleman, N., Wreghitt, T. G., Wight, D. G., and Alexan-der, G. J. (1999). Cytomegalovirus infection of bile duct epithe-lial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grafts. J. Hepatol., 31, 913-920.
88. Everett, J. P., Hershberger, R. E., Norman, D. J. et al. (1992). Pro-longed cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J. Heart Lung Transpl.
89. Farber, S. and Wolbach, S. B. (1932). Intranuclear and cytoplasmic inclusions (protozoan-like bodies) in the salivary glands and other organs of infants. Am. J. Pathol. Child., 8, 123-126.
90. Fish, K. N., Stenglein, S. G., Ibanez, C., and Nelson, J. A. (1995). Cytomegalovirus persistence in macrophages and endothelial cells. Scand. J. Infect. Dis.-Sppl. 99, 34-40.
91. Fish, K. N., Soderberg-Naucler, C., Mills, L. K., Stenglein, S., and Nelson, J. A. (1998). Human cytomegalovirus persistently infects aortic endothelial cells. J. Virol., 72, 5661-5668.
92. Fleming, P., Davis-Poynter, N., Degli-Eposti, M. et al. (1999). The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. J. Virol., 73, 6800-6809.
93. Fortunato, E. A., McElroy, A. K., Sanchez, I., and Spector, D. H. (2000). Exploitation of cellular signaling and regulatory path-ways by human cytomegalovirus. Trends Microbiol., 8, 111-119.
94. Foster, K. M. and Jack, I. (1969). A prospective study of the role of cytomegalovirus in post-transfusion mononucleosis. N. Engl. J. Med., 280, 1311-1315.
95. Fowler, K. B. and Pass, R. F. (1991). Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infec-tion. J. Infect. Dis., 164, 259-264.
96. Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J., and Alford, C. A. (1992). The outcome of congenital cytomegalovirus infec-tion in relation to maternal antibody status. N. Engl. J. Med., 326, 663-667.
97. Fowler, K. B., Stagno, S., and Pass, R. F. (1993). Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980-1990. J. Infect. Dis., 168, 552-556.
98. Fowler, K. B., Pass, R. F., and Stagno, S. (1997). Presented at the Society for Pediatric Epidemiological Research 10th Annual Meeting, Edmonton, Alberta, Canada, June 10-11.
99. Francis, N. D., Boylston, A. W., Roberts, A. H., Parkin, J. M., and Pinching, A. J. (1989). Cytomegalovirus infection in gastroin-testinal tracts of patients infected with HIV-1 or AIDS. J. Clin. Pathol., 42, 1055-1064.
100. Gallant, J. E., Moore, R. D., Richman, D. D., Keruly, J., and Chaisson, R. E. (1992). Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epi-demiology Study Group. J. Infect. Dis., 166, 1223-1227
101. Geder, L., Sanford, E. J., Rohner, T. J., and Rapp, F. (1977). Cytomegalovirus and cancer of the prostate: In vitro transfor-mation of human cells. Cancer Treat. Rep., 61, 139-146.
102. Gerna, G., Zipeto, D., Parea, M. et al. (1991). Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigene-mia, and DNAemia. J. Infect. Dis., 164, 488-498.
103. Gerna, G., Zipeto, D., Percivalle, E. et al. (1992). Human cytomegalovirus infection of the major leukocyte subpopu-lations and evidence for initial viral replication in polymor-phonuclear leukocytes from viremic patients. J. Infect. Dis., 166, 1236-1244.
104. Gerna, G., Zavattoni, M., Baldanti, F. et al. (1998). Circulating cytomegalic endothelial cells are associated with high human cytomegalovirus (HCMV) load in AIDS patients with late-stage disseminated HCMV disease. J. Med. Virol., 55, 64-74.
105. Gerna, G., Percivalle, E., Baldanti, F. et al. (2000). Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J. Virol., 74, 5629-5638.
106. Gerna, G., Percivalle, E., Baldanti, F., and Revello, M. G. (2002). Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J. Med. Virol., 66, 335-339.
107. Gnann, J. W., Jr., Ahlmen, J., Svalander, C., Olding, L., Oldstone, M. B., and Nelson. J. A. (1988). Infiammatory cells in trans-planted kidneys are infected by human cytomegalovirus. Am. J. Pathol., 132, 239-248.
108. Gold, E. and Nankervis. G. A.(1982). Cytomegalovirus. In Viral Infec-tions of Humans: Epidemiology and Control, 2nd ed, ed. A. S. Evans, pp.167-186. New York: Plenum Press.
109. Goldmacher, V. S., Bartle, L. M., Skaletskaya, A. et al. (1999). A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl Acad. Sci. USA, 96, 12536-12541.
110. Goodpasture, E. W. and Talbot, F. B. (1921). Concerning the nature of proteozoan-like cells in certain lesions of infancy. Am. J. Dis. Child., 21, 415-421.
111. Goodrich, J. M., Bowden, R. A., Fisher, L. et al. (1993). Ganci-clovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med., 118, 173-178.
112. Goodrum, F. D., Jordan, C. T., High, K., and Shenk, T. (2002). Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: A model for latency. Proc. Natl Acad. Sci. USA, 99, 16255-16260.
113. Grattan, M. T., Moreno-Cabral, C. E., Starnes, V. A., Oyer, P. E., Stinson, E. B., and Shumway. N. E. (1989). Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J. Am. Med. Assoc., 261, 3561-3566.
114. Grefte, A., vander Giessen, M., van Son, W., and The, T. H.(1993). Cir-culating cytomegalovirus (CMV)-infected endoethelial cells in patients with an active CMV infection. J. Infect. Dis., 167, 270-277.
115. Griffiths, P. D., Clark, D. A., and Emery, V. C. (2000). Betaher-pesviruses in transplant recipients. J. Antimicrob. Chemother., 45, 29-34.
116. Grose, C. (1994). Varicella zoster virus infections: Chickenpox, shingles, and varicella vaccine. In Herpesvirus Infections, ed. R. Glaser and J. F. Jones, pp. 117-185. New York: Marcel Dekker, Inc.
117. Grundy, J. E., Shanley, J. D., and Griffiths, P. D. (1987). Is cytomegalovirus interstitial pneumonitis in transplant recipi-ents an immunopathological conditionfi Lancet, 2, 996-999.
118. Grundy, J. E., Lui, S. F., Super, M. et al. (1988). Symptomatic cytomegalovirus infection in seropositive kidney recipients: Reinfection with donor virus rather than reactivation of recip-ient virus. Lancet, 2, 132-135.
119. Grundy, J. E., Lawson, K. M., MacCormac, L. P., Fletcher, J. M., and Yong, K. L. (1998). Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration. J. Infect. Dis., 177, 1465-1474.
120. Guetta, E., Guetta, V., Shibutani, T., and Epstein, S. E. (1997). Mono-cytes harboring cytomegalovirus: Interactions with endothe-lial cells, smooth muscle cells, and oxidized low-density lipoprotein. Possible mechanisms for activating virus deliv-ered by monocytes to sites of vascular injury. Circ. Res., 81, 8-16.
121. Hahn, G., Jores, R., and Mocarski, E. S. (1998). Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl Acad. Sci. USA, 95, 3937-3942.
122. Hahn, G., Khan, H., Baldanti, F., Koszinowski, U. H., Revello, M. G., and Gerna, G. (2002). The human cytomegalovirus ribonu-cleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics. J. Virol., 76, 9551-9555.
123. Hahn, G., Revello, M. G., Patrone, M., et al. (2004). Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol., 78, 10023-10033.
124. Hamprecht, K., Vochem, M., Baumeister, A., Boniek, M., Speer, C. P., and Jahn, G. (1998). Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR. J. Virol. Method, 70, 167-176.
125. Handsfield, H. H., Chandler, S. H., Caine, V. A. et al. (1985). Cytomegalovirus infection in sex partners: Evidence for sex-ual transmission. J. Infect. Dis., 151, 344-348.
126. Hanshaw, J. B. (1971). Congenital cytomegalovirus infection: A fif-teen year perspective. J. Infect. Dis., 123, 555-561.
127. Hanson, L. K., Slater, J. S., Karabekian, Z. et al. (1999). Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J. Virol., 73, 5970-5980.
128. Hanson, L. K., Slater, J. S., Karabekian, Z., Ciocco-Schmitt, G., and Campbell, A. E. (2001). Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen. J. Virol., 75, 6292-6302.
129. Harkins, L., Volk, A. L., Samanta, M. et al. (2002). Specific localisa-tion of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet, 360, 1557-1563.
130. Ho, M. (1977). Virus infections after transplantation in man. Arch. Virol., 55, 1-24.
131. Holland, G. N. (1999). Immune recovery uveitis. Ocular Immunol. Infiammation, 7, 215-221.
132. Holsward, T. R., Engle, M. A. Redo, S. F. Goldsmith, E. I., and Baron-dess, J. A. (1963). Development of viral diseases and a viral disease-like syndrome after extracorporeal circulation. Circu-lation, 27, 812-815.
133. Hosenpud, J. D. (1999). Coronary artery disease after heart trans-plantation and its relation to cytomegalovirus. Am. Heart J., 138, S469-S472.
134. Hsieh, C. Y., You, S. L., Kao, C. L., and Chen, C. J. (1999). Reproduc-tive and infectious risk factors for invasive cervical cancer in Taiwan. Anticancer Res., 19, 4495-4500.
135. Huang, E. S. and Pagano. J. S. (1978). Cytomegalovirus DNA and adenocarcinoma of the colon: Evidence for latent infection. Lancet, 1, 957-960.
136. Hummel, M., Zhang, Z., Yan, S. et al. (2001). Allogeneic transplanta-tion induces expression of cytomegalovirus immediate-early genes in vivo: A model for reactivation from latency. J. Virol., 75, 4814-4822.
137. Hutto, S. C., Ricks, R. E., Garvie, M., and Pass, R. F. (1985). Epidemiol-ogy of cytomegalovirus infections in young children: Day care vs home care. Pediatr. Infect. Dis., 4, 149-152.
138. Hutto, C., Little, E. A., Ricks, R., Lee, J. D., and Pass, R. F. (1986). Isolation of cytomegalovirus from toys and hands in a day care center. J. Infect. Dis., 154, 527-530.
139. Jacobson, M. A., O'Donnell, J. J., Porteus, D., Brodie, H. R., Feigal, D., and Mills, J. (1988). Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune defi-ciency syndrome: Prevalence, natural history and response to ganciclovir therapy. Quart. J. Med., 67, 473.
140. Jahn, G., Stenglein, S., Riegler, S., Einsele, H., and Sinzger, C. (1999). Human cytomegalovirus infection of immature dendritic cells and macrophages. Intervirology, 42, 365-372.
141. Jarvis, M. A., Wang, C. E., Meyers, H. L. et al. (1999). Human cytomegalovirus infection of Caco-2 cells occurs at the basolat-eral membrane and is differentiation state dependent. J. Virol., 73, 4552-4560.
142. Jesionek, A. and Kiolemenoglou, B. (1904). Uber einen befund von protozoenartigen gebilden in den organen eines heridi-tarluetischen fotus. Munch. Med. Wochenschr., 51, 1905-1907.
143. Jonjic, S., Pavic, I., Polic, B., Crnkovic, I., Lucin, P., and Koszinowski, U. H. (1994). Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med., 179, 1713-1717.
144. Jordan, M. C. and Mar, V. L. (1982). Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lym-phocytes and macrophages in release and replication of virus. J. Clin. Invest., 70, 762-768.
145. Jordan, M. C., Rousseau, W. E., Noble, G. R., Stewart, J. A., and Chin, T. D. Y. (1973). Association of cervical cytomegaloviruses with venereal disease. N. Engl. J. Med., 288, 932-934.
146. Jordan, M. C., Takagi, J. L., and Stevens, J. G. (1982). Activa-tion of latent murine cytomegalovirus in vivo and in vitro: A pathogenetic role for acute infection. J. Infect. Dis., 145, 699-705.
147. Kahl, M., Siegel-Axel, D., Stenglein, S., Jahn, G., and Sinzger, C. (2000). Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains. J. Virol., 74, 7628-7635.
148. Kalejta, R. F. and Shenk, T. (2002). Manipulation of the cell cycle by human cytomegalovirus. Frontiers Biosci., 7, d295-d306.
149. Kalejta, R. F. and Shenk, T. (2003). The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J. Virol., 77, 3451-3459.
150. Kalejta, R. F., Bechtel, J. T., and Shenk, T. (2003). Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol., 23, 1885-1895.
151. Kaplan, C. S., Petersen, E. A., Icenogle, T. B. et al. (1989). Gas-trointestinal cytomegalovirus infection in heart and heart-lung transplant recipients. Arch. Intern. Med., 149, 2095-2100.
152. Karavellas, M. P., Lowder, C. Y., Macdonald, C., Avila, C. P., Jr., and Freeman, W. R. (1998). Immune recovery vitritis associated with inactive cytomegalovirus retinitis: A new syndrome. Arch. Ophthalmol., 116, 169-175.
153. Kas-Deelen, A. M., de Maar, E. F., Harmsen, M. C., Driessen, C., van Son, W. J., and The, T. H. (2000). Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: Effect of acute rejection. J. Infect. Dis., 181, 721-724.
154. Kas-Deelen, A. M., The, T. H., Blom, N. et al. (2001). Uptake of pp65 in in vitro generated pp65-positive polymorphonuclear cells mediated by phagocytosis and cell fusionfi Intervirology, 44, 8-13.
155. Kern, E. R. (1999). Animal models for cytomegalovirus infection: Murine CMV. In Handbook of Animal Models of Infection, ed. O. Zak and M. Sande, pp. 927-934. London: Academic Press.
156. Klatt, E. C. and Shibata, D. (1988). Cytomegalovirus infection in the acquired immunodeficiency syndrome. Clinical and autopsy findings. Arch. Pathol. Lab. Med., 112, 540-544.
157. Kledal, T. N., Rosenkilde, M. M., and Schwartz, T. W. (1998). Selec-tive recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett., 441, 209-214.
158. Kondo, K., Xu, J., and Mocarski, E. S. (1996). Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive indi-viduals. Proc. Natl. Acad. Sci. USA, 93, 11137-11142.
159. Koskinen, P. K. (1993). The association of the induction of vascular cell adhesion molecule-1 with cytomegalovirus antigenemia in human heart allografts. Transplantation, 56, 1103-1108.
160. Koskinen, P. K., Nieminen, M. S., Krogerus, L. A. et al. (1993). Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J. Heart Lung Transpl., 12, 724-729.
161. Koskinen, P., Lemstrom, K., Bruggeman, C., Lautenschlager, I., and Hayry, P. (1994). Acute cytomegalovirus infection induces a subendothelial infiammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arte-riosclerosis. Am. J. Pathol., 144, 41-50.
162. Koskinen, P. K., Kallio, E. A., Tikkanen, J. M., Sihvola, R. K., Hayry, P. J., and Lemstrom, K. B. (1999). Cytomegalovirus infec-tion and cardiac allograft vasculopathy. Transpl. Infect. Dis., 1, 115-126.
163. Kosugi, I., Shinmura, Y., Li, R. Y. et al. (1998). Murine cytomegalovirus induces apoptosis in non-infected cells of the developing mouse brain and blocks apoptosis in primary neu-ronal culture. Acta Neuropath., 96, 239-247.
164. Kotenko, S. V., Saccani, S., Izotova, L. S., Mirochnitchenko, O. V., and Pestka, S. (2000). Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl Acad. Sci. USA, 97, 1695-1700.
165. Krech, U. and Tobin, J. (1981). A collaborative study of cytomegalovirus antibodies in mothers and young children in 19 countries. Bull. WHO, 59, 605-610.
166. Kurz, S., Steffens, H. P., Mayer, A., Harris, J. R., and Reddehase, M. J. (1997). Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol., 71, 2980-2987.
167. Kurz, S. K., Rapp, M., Steffens, H. P., Grzimek, N. K., Schmalz, S., and Reddehase, M. J. (1999). Focal transcriptional activity of murine cytomegalovirus during latency in the lungs. J. Virol., 73, 482-494.
168. Landry, M. L. and Ferguson, D. (1993). Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J. Clin. Microbiol., 31, 2851-2856.
169. Lang, D. J. and Kummer, J. F. (1975). Cytomegalovirus in semen: Observations in selected populations. J. Infect. Dis., 132, 472-473.
170. Lemstrom, K., Koskinen, P., Krogerus, L., Daemen, M., Bruggeman, C., and Hayry, P. (1995). Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat car-diac allografts after cytomegalovirus infection. Circulation, 92, 2594-2604.
171. Lemstrom, K., Sihvola, R., Bruggeman, C., Hayry, P., and Koskinen, P. (1997). Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Cir-culation, 95, 2614-2616.
172. Li, F., Yin, M., Van Dam, J. G., Grauls, G., Rozing, J., and Bruggeman, C. A. (1998). Cytomegalovirus infection enhances the neoin-tima formation in rat aortic allografts: Effect of major histo-compatibility complex class I and class II antigen differences. Transplantation, 65, 1298-1304.
173. Liapis, H., Storch, G. A., Hill, D. A., Rueda, J., and Brennan, D. C. (2003). CMV infection of the renal allograft is much more com-mon than the pathology indicates: A retrospective analysis of qualitative and quantitative buffy coat CMV-PCR, renal biopsy pathology and tissue CMV-PCR. Nephrol. Dial. Transpl., 18, 397-402.
174. Libby, P. (2002). Infiammation in atherosclerosis. Nature, 420, 868-874.
175. Libby, P. (2003). Vascular biology of atherosclerosis: Overview and state of the art. Am. J. Cardiol., 91, 3A-6A.
176. Liesnard, C. A., Revelard, P., and Englert, Y. (1998). Is matching between women and donors feasible to avoid cytomegalovirus infection in artificial insemination with donor semenfi [comment]. Hum. Reprod., 13, 25-31; discussion 32-34.
177. Ljungman, P. (2002). Beta-herpesvirus challenges in the transplant recipient. J. Infect. Dis., 186, S99-S109.
178. Ljungman, P., Griffiths, P., and Paya, C. (2002a). Definitions of cytomegalovirusinfectionanddiseaseintransplantrecipients. Clin. Infect. Dis., 34, 1094-1097.
179. Ljungman, P., Larsson, K. Kumlien, G. et al. (2002b). Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors. Scand. J. Infect. Dis., 34, 347-350.
180. Lockridge, K. M., Sequar, G., Zhou, S. S., Yue, Y., Mandell, C. P., and Barry, P. A. (1999). Pathogenesis of experimental rhesus cytomegalovirus infection. J. Virol., 73, 9576-9583.
181. Loebe, M., Schuler, S., Zais, O., Warnecke, H., Fleck, E., and Hetzer, R. (1990). Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J. Heart Transpl., 9, 707-711.
182. MacDonald, M. R., Burney, M. W., Resnick, S. B., and Virgin, H. I. (1999). Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel struc-ture. J. Virol., 73, 3682-3691.
183. Maidji, E., Percivalle, E., Gerna, G., Fisher, S., and Pereira, L. (2002). Transmission of human cytomegalovirus from infected uter-ine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. Virology, 304, 53-69.
184. Margulies, B. J., Browne, H., and Gibson, W. (1996). Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology, 225, 111-125.
185. Mattes, F. M., McLaughlin, J. E., Emery, V. C., Clark, D. A., and Griffiths, P. D. (2000). Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7. J. Clin. Pathol., 53, 612-614
186. McDonald, K., Rector, T. S., Braulin, E. A., Kubo, S. H., and Olivari, M. T. (1989). Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am. J. Cardiol., 64, 359-362.
187. Melnick, J. L., Adam, E., and Debakey, M. E. (1993). Cytomegalovirus and atherosclerosis. Eur. Heart. J., 14, 30-38.
188. Menard, C., Wagner, M., Ruzsics, Z. et al. (2003). Role of murine cytomegalovirus US22 gene family members in replication in macrophages. J. Virol., 77, 5557-5570.
189. Mendez, J., Espy, M., Smith, T. F., Wilson, J., Wiesner, R., and Paya, C. V. (1998). Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Trans-plantation, 65, 1477-1481.
190. Minamishima, I., Ueda, K., Minematsu, T. etal.(1994). Roleofbreast milk in acquisition of cytomegalovirus infection. Microbiol. Immunol., 38, 549-552.
191. Mitchell, B. M., Leung, A., and Stevens, J. G. (1996). Murine cytomegalovirus DNA in peripheral blood of latently infected mice is detectable only in monocytes and polymorphonuclear leukocytes. Virology, 223, 198-207.
192. Mocarski, E. S., Jr. (2002). Immunomodulation by cytomega-loviruses: Manipulative strategies beyond evasion. Trends Microbiol., 10, 332-339.
193. Morgello, S., Cho, E. S., Nielson, S., Devinsky, O., and Petito, C. K. (1987). Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: An autopsy study of 30 cases and a review of the literature. Hum. Pathol., 18, 289-297.
194. Moro, D., Lloyd, M. L., Smith, A. L., Shellam, G. R., and Lawson, M. A. (1999). Murine viruses in an island population of intro-duced house mice and endemic short-tailed mice in Western Australia. J. Wildlife Dis., 35, 301-310.
195. Murph, J. R., Bale, J. F., Murray, J. C., Stinski, M. F., and Perlman, S. (1986). Cytomegalovirus transmission in a Midwest day care center: Possible relationship to child care practices. J. Pediatr., 109, 35-39.
196. Murph, J. R., Baron, J. C., Brown, K., Ebelhack, C. L., and Bale, J. F. (1991). The occupational risk of cytomegalovirus infec-tion among day care providers. J. Am. Med. Assoc., 265, 603-608.
197. Mutimer, H. P., Akatsuka, Y., Manley, T. et al. (2002). Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J. Infect. Dis., 186, 701-705.
198. Myers, J. D., Spencer, H. C., Jr., Watts, J. C. et al. (1975). Cytomegalovirus pneumonia after human marrow transplan-tation. Ann. Int. Med., 82, 181-188.
199. Myerson, D., Hackman, R. C., Nelson, J. A. et al. (1984). Widespread presence of histologically occult cytomegalovirus. Hum. Pathol., 15, 430-439.
200. Nichols, W. G. and Boeckh, M. (2000). Recent advances in the ther-apy and prevention of CMV infections. J. Clini. Virol., 16, 25-40.
201. Nichols, W. G., Corey, L., Gooley, T. et al. (2001). Rising pp65 anti-genemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: Risk fac-tors, correlation with DNA load, and outcomes. Blood, 97, 867-874.
202. Nieto, F. J., Adam, E., Sorlie, P. et al. (1996). Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation, 94, 922-927.
203. Noda, S., Aguirre, S. A., Bitmansour, A. et al. (2006) Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood, 107, 30-38.
204. O'Connor, S., Taylor, C., Campbell, L. A., Epstein, S., and Libby, P. (2001). Potential infectious etiologies of atherosclerosis: A multifactorial perspective. Emerg. Infect. Dis., 7, 780-788.
205. Odeberg, J., Cerboni, C., Browne, H. et al. (2002). Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis inde-pendent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand. J. Immunol., 55, 149-161.
206. Oliveira, S. A. and Shenk, T. E. (2001). Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. Proc. Natl Acad. Sci. USA, 98, 3237-3242.
207. Paloheimo, J. A., von Essen, R., Klemola, E., Kaariainen, L., and Siltanen, P. (1968). Subclinical cytomegalovirus infections and cytomegalovirus mononucleosis after open heart surgery. Am. J. Cardiol., 22, 624-630.
208. Pass, R. F., Stagno, S., Myers, G. J., and Alford, C. A. (1980). Outcome of symptomatic congenital CMV infection: Results of long-term longitudinal follow-up. Pediatrics, 66, 758-762.
209. Pass, R. F., August, A. M., Dworsky, M. E., and Reynolds, D. W. (1982a). Cytomegalovirus infection in a day care center. N. Engl. J. Med., 307, 477-479.
210. Pass, R. F., Stagno, S., Dworsky, M. E., Smith, R. J., and Alford, C. A. (1982b). Excretion of cytomegalovirus in mothers: Observation after delivery of congenitally infected and normal infants. J. Infect. Dis., 146, 1-6.
211. Pass, R. F., Hutto, C., Reynolds, D. W., and Polhill, R. B. (1984). Increased frequency of cytomegalovirus in children in group day care. Pediatrics, 74, 121-126.
212. Pass, R. F., Hutto, S. C., Ricks, R., and Cloud, G. A. (1986). Increased rate of cytomegalovirus infection among parents of chil-dren attending day care centers. N. Engl. J. Med., 314, 1414-1418.
213. Pass, R. F., Little, E. A., Stagno, S., Britt, W. J., and Alford, C. A. (1987). Young children as a probable source of maternal and con-genital cytomegalovirus infection. N. Engl. J. Med., 316, 1366-1370.
214. Pass, R. F., Hutto, C., Lyon, M. D., and Cloud, G.(1990). Increasedrate of cytomegalovirus infection among day care center workers. Pediatr. Infect. Dis. J., 9, 465-470.
215. Pecorella, I., Ciardi, A., Garner, A., McCartney, A. C., and Lucas, S. (2000). Postmortem histological survey of the ocular lesions in a British population of AIDS patients. Br. J. Ophthalmol., 84, 1275-1281.
216. Penfold, M. E., Dairaghi, D. J., Duke, G. M. et al. (1999). Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl Acad. Sci. USA, 96, 9839-9844.
217. Penfold, M. E., Schmidt, T. L., Dairaghi, D. J., Barry, P. A., and Schall, T. J. (2003). Characterization of the rhesus cytomegalovirus US28 locus. J. Virol., 77, 10404-10413.
218. Pepose, J. S., Holland, G. N., Nestor, M. S., Cochran, A. J., and Foos, R. Y. (1985). Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease. Ophthalmology, 92, 472-484.
219. Pepose, J. S., Newman, C., Bach, M. C. et al. (1987). Pathologic fea-tures of cytomegalovirus retinopathy after treatment with the antiviral agent ganciclovir. Ophthalmology, 94, 414-424.
220. Percivalle, E., Revello, M. G., Vago, L., Morini, F., and Gerna, G. (1993). Circulating endothelial giant cells permissive for humancytomegalovirus(HCMV) aredetectedindisseminated HCMV infections with organ involvement. J. Clin. Invest., 92, 663-670.
221. Perlman, J. M. and Argyle, C. (1992). Lethal cytomegalovirus infec-tion in preterm infants: Clinical, radiological, and neuropatho-logical findings. Ann. Neurol., 31, 64-68.
222. Peterson, P. K., Balfour, H. H., Marker, S. C. et al. (1980). Cytomegalovirus disease in renal allograft recipients: A prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine, 59, 283-300.
223. Petrie, B. L., Adam, E., and Melnick, J. L. (1988). Association of her-pesvirus/cytomegalovirus infections with human atheroscle-rosis. Progr. Med. Virol., 35, 21-42.
224. Plachter, B., Sinzger, C., and Jahn, G. (1996). Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res., 46, 195-261.
225. Plotkin, S. A., Starr, S. E., Friedman, H. M. et al. (1989). Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis., 159, 860-865.
226. Plotkin, S. A., Starr, S. E., Friedman, H. M. et al. (1991). Effect of Towne live virus vaccine on cytomegalovirus disease after renal transplant. A controlled trial. Ann. Intern. Med., 114, 525-531.
227. Pooley, R. J., Jr., Peterson, L., Finn, W. G., and Kroft, S. H. (1999). Cytomegalovirus-infected cells in routinely prepared periph-eral blood films of immunosuppressed patients. Am. J. Clin. Pathol., 112, 108-112.
228. Prince, A. M., Szumuness, W., Millian, S. J., and David, D. S. (1971). A serologic study of cytomegalovirus infections associated with blood transfusions. N. Engl. J. Med., 284, 1125-1131.
229. Randolph-Habecker, J. R., Rahill, B., Torok-Storb, B. et al. (2002). The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. Cytokine, 19, 37-46.
230. Rapp, F. and Robbins, D. (1984). Cytomegalovirus and human can-cer. Birth Defects: Original Article Series, 20, 175-192.
231. Reddehase, M. J., Balthesen, M., Rapp, M., Jonjic, S., Pavic, I., and Koszinowski, U. H. (1994). The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. J. Exp. Med., 179, 185-193.
232. Reddehase, M. J., Podlech, J., and Grzimek, N. K. (2002). Mouse models of cytomegalovirus latency: Overview. J. Clin. Virol., 25, S23-S36.
233. Redman, T. K., Britt, W. J., Wilcox, C. M., Graham, M. F., and Smith, P. D. (2002). Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages. J. Infect. Dis., 185, 584-590.
234. Reed, E. C., Wolford, J. L., Kopecky, K. J., Lilleby, K. E., Dandliker, P. S., and Todaro, J. L. (1990). Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial. Ann. Intern. Med., 112, 505-510.
235. Reyman, T. A. (1966). Postperfusion syndrome: A review and report of 21 cases. Am. Heart J., 72, 116-123.
236. Reynolds, D. W., Stagno, S., Hosty, T. S., Tiller, M., and Alford, C. A. (1973). Maternal cytomegalovirus excretion and perinatal infection. N. Engl. J. Med., 289, 1-5.
237. Ribalta, T., Martinez, A. J., Jares, P. et al. (2002). Presence of occult cytomegalovirus infection in the brain after orthotopic liver transplantation. An autopsy study of 83 cases. [see comment]. Virchows Arch., 440, 166-171.
238. Ribbert, D. (1904). Uber protozoenartige zellen in der niere eines syphilitischen neugoborenen und in der parotis von kindern. Zentralbl. Allg. Pathol., 15, 945-948.
239. Rice, G. P. A., Schrier, R. D., and Oldstone, M. B. A. (1984). Cytomegalovirus infects human lymphocytes and monocytes: Virus expression is restricted to immediate-early gene prod-ucts. Proc. Natl. Acad. Sci. USA, 81, 6134.
240. Richardson, W. P., Colvin, R. B., Cheeseman, S. H. et al. (1981). Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N. Engl. J. Med., 305, 57-63.
241. Riegler, S., Hebart, H., Einsele, H., Brossart, P., Jahn, G., and Sinzger, C. (2000). Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J. Gen. Virol., 81, 393-399.
242. Rifkind, D. (1965). Cytomegalovirus infection after renal transplan-tation. Arch. Intern. Med., 116, 554-558.
243. Rinaldo, C. R., Jr., Kingsley, L. A., Ho, M., Armstrong, J. A., and Zhou, Y. (1992). Enhanced shedding of cytomegalovirus in semen of human immunodeficiency virus-seropositive homosexual men. J. Clin. Microbiol., 30, 1148-1155.
244. Roback, J. D., Hillyer, C. D., Drew, W. L. et al. (2001). Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion., 41, 1249-1257.
245. Rosenkilde, M. M., Waldhoer, M., Luttichau, H. R., and Schwartz, W. (2001). Virally encoded 7TM receptors. Oncogene, 20, 1582-1593.
246. Rubin, R. H. (1990). Impact of cytomegalovirus infection on organ transplant recipients. Rev. Infect. Dis., 12, S754-S766.
247. Rubin, R. (2002). Clinical approach to infection in the compro-mised host, In Infection in the Organ Transplant Recipi-ent, ed. R. Rubin, pp. 573-679 New York: Kluwer Academic Press.
248. Rubin, R. H. and Colvin, R. B. (1986). Cytomegalovirus infection in renal transplantation: Clinical importance and control. In Kidney Transplant Rejection: Diagnosis and Treatment, ed. G. M. Williams, J. F. Burdick, and K. Solez, pp. 283-304. New York: Dekker.
249. Rubin, R. H., Russell, P. S., Levin, M., and Cohen, C. (1979). From the National Institutes of Health. Summary of a workshop on cytomegalovirus infections during organ transplantation. J. Infect. Dis., 139, 728-734.
250. Rubin, R. H., Wolfson, J. S., Cosimi, A. B. et al. (1981). Infection in the renal transplant recipient. Am. J. Med., 70, 405-411.
251. Saederup, N., Lin, Y. C., Dairaghi, D. J., Schall, T. J., and Mocarski, E. S. (1999). Cytomegalovirus-encoded beta chemokine pro-motes monocyte-associated viremia in the host. Proc. Natl Acad. Sci. USA, 96, 10881-10886.
252. Saederup, N., Aguirre, S. A., Sparer, T. E., Bouley, D. M., and Mocarski, E. S. (2001). Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemina-tion that increases infiammation at initial sites of infection. J. Virol., 75, 9966-9976.
253. Saederup, N. and Mocarski, E. S. Jr, (2002). Fatal attraction: Cytomegalovirus-encoded chemokine homologs. Curr. Top. Microbiol. Immunol., 269, 235-256.
254. Salzberger, B., Myerson, D., and Boeckh, M. (1997). Circulating cytomegalovirus (CMV)-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection. J. Infect. Dis., 176, 778-781.
255. Schafer, P., Tenschert, W., Cremaschi, L., Schroter, M., Gutensohn, K., and Laufs, R. (2000). Cytomegalovirus cultured from dif-ferent major leukocyte subpopulations: Association with clini-cal features in CMV immunoglobulin G-positive renal allograft recipients. J. Med. Virol., 61, 488-496.
256. Schmidbauer, M., Budka, H., Ulrich, W., and Ambros, P. (1989). Cytomegalovirus (CMV) disease of the brain in AIDS and con-natal infection: A comparative study by histology, immunocy-tochemistry and in situ DNA hybridization. Acta Neuropathol. (Berl.), 79, 286-293.
257. Schmidt, G. M., Horak, D. A., Niland, J. C., Duncan, S. R., Forman, S. J., and Zaia, J. A. (1991). A randomized, controlled trial of pro-phylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. N. Engl. J. Med., 324, 1005-1011.
258. Sedmak, D. D., Knight, D. A., Vook, N. C., and Waldman, J. W. (1994). Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expres-siononcytomegalovirus-infectedendothelialcells. Transplan-tation, 58, 1379-1385.
259. Selik, R. M., Chu, S. Y., and Ward, J. W. (1996). Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann. Intern. Med., 123, 933-936.
260. Sequar, G., Britt, W. J., Lakeman, F. D. et al. (2002). Experimental coinfection of rhesus macaques with rhesus cytomegalovirus and simian immunodeficiency virus: Pathogenesis. J. Virol., 76, 7661-7671.
261. Shen, C. Y., Ho, M. S., Chang, S. F. et al. (1993). High rate of con-current genital infections with human cytomegalovirus and human papillomaviruses in cervical cancer patients. J. Infect. Dis., 168, 449-452.
262. Shen, Y., Zhu, H., and Shenk, T. (1997). Human cytomagalovirus IE1 and IE2 proteins are mutagenic and mediate hit-and-run oncogenic transformation in cooperation with the ade-novirus E1A proteins. Proc. Natl Acad. Sci. USA, 94, 3341-3345.
263. Sinclair, J. and Sissons, P. (1996). Latent and persistent infections of monocytes and macrophages. Intervirology, 39, 293-301.
264. Singh, N., Dummer, J. S., Kusne, S. et al. (1988). Infections with cytomegalovirus and other herpesviruses in 121 liver trans-plant recipients: Transmission by donated organ and the effect of OKT3 antibodies. J. Infect. Dis., 158, 124-131.
265. Singh, N., Paterson, D. L., Gayowski, T., Wagener, M. M., and Marino, I. R. (2000). Cytomegalovirus antigenemia directed pre-emptive prophylaxis with oral versus I.V. ganciclovir for the prevention of cytomegalovirus disease in liver transplant recipients: A randomized, controlled trial. Transplantation, 70, 717-722.
266. Sinzger, C. and Jahn, G. (1996). Human cytomegalovirus cell tropism and pathogenesis. Intervirology, 39, 302-319.
267. Sinzger, C., Grefte, A., Plachter, B., Gouw, A. S., The, T. H., and Jahn, G. (1995). Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol., 76, 741-750.
268. Sinzger, C., Knapp, J., Plachter, B., Schmidt, K., and Jahn, G. (1997). Quantification of replication of clinical cytomegalovirus iso-lates in cultured endothelial cells and fibroblasts by a focus expansion assay. J. Virol. Methods, 63, 103-112.
269. Sinzger, C., Schmidt, K., Knapp, J. et al. (1999). Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol., 80, 2867-2877.
270. Sinzger, C., Kahl, M., Laib, K. et al. (2000). Tropism of human cytomegalovirus for endothelial cells is determined by a post-entry step dependent on efficient translocation to the nucleus. J. Gen. Virol., 81, 3021-3035.
271. Soderberg-Naucler, C. and Emery, V. C. (2001). Viral infections and their impact on chronic renal allograft dysfunction. Transplan-tation., 71, SS224-SS230.
272. Soderberg-Naucler, C., Fish, K. N., and Nelson, J. A. (1997). Reacti-vation of latent human cytomegalovirus by allogeneic stimu-lation of blood cells from healthy donors. Cell, 91, 119-126.
273. Soderberg-Naucler, C., Fish, K. N., and Nelson, J. A. (1998). Growth of human cytomegalovirus in primary macrophages. Methods (Duluth), 16, 126-138.
274. Soderberg-Naucler, C., Streblow, D. N., Fish, K. N., Allan-Yorke, J., Smith, P. P., and Nelson, J. A. (2001). Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differen-tiation dependent. J. Virol., 75, 7543-7554.
275. Sohn, Y. M., Oh, M. K., Balcarek, K. B., Cloud, G. A., and Pass, R. F. (1991). Cytomegalovirus infection in sexually active ado-lescents. J. Infect. Dis., 163, 460-463.
276. Spector, S. A. and Spector, D. H. (1982). Molecular epidemiology of cytomegalovirus infections in premature twin infants and their mother. Pediatr. Infect. Dis. J., 1, 405-409.
277. Spector, S. A., Hirata, K. K., and Newman, T. R. (1984). Identification of multiple cytomegalovirus strains in homosexual men with acquiredimmunodeficiencysyndrome. J. Infect. Dis., 150, 953-956.
278. Spector, S. A., Wong, R., Hsia, K., Pilcher, M., and Stempien, M. J. (1998). Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest., 101, 497-502.
279. Spector, S. A., Hsia, K., Crager, M., Pilcher, M., Cabral, S., and Stem-pien, M. J. (1999). Cytomegalovirus (CMV) DNA load is an inde-pendent predictor of CMV disease and survival in advanced AIDS. J. Virol., 73, 7027-7030.
280. Speir, E., Modali, R., Huang, E. S. et al. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science, 265, 391-394.
281. Speir, E., Yu, Z. X., Ferrans, V. J., Huang, E. S., and Epstein, S. E. (1998). Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res., 83, 210-216.
282. Spencer, J. V., Lockridge, K. M., Barry, P. A. et al. (2002). Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. J. Virol., 76, 1285-1292.
283. Stagno, S. (1995). Cytomegalovirus, In Infectious Diseases of the Fetus and Newborn Infant, 4th ed, ed. J. S. Remington and J. O. Klein, pp. 312-353. Philadelphia: W.B. Saunders.
284. Stagno, S., Reynolds, D. W., Tsiantos, A. et al. (1975a). Cervi-cal cytomegalovirus excretion in pregnant and nonpregnant women: Suppression in early gestation. J. Infect. Dis., 131, 522-527.
285. Stagno, S., Reynolds, D. W., Tsiantos, A., Fucillo, D. A., Long, W., and Alford, C. A. (1975b). Comparative, serial virologic and serologic studies of symptomatic and subclinical congenital and natally acquired cytomegalovirus infection. J. Infect. Dis., 132, 568-577.
286. Stagno, S., Reynolds, D. W., Amos, C. S. et al. (1977). Auditory and visual defects resulting from symptomatic and subclinical con-genital cytomegaloviral and toxoplasma infections. Pediatrics, 59, 669-678.
287. Stagno, S., Reynolds, D. W., Pass, R. F., and Alford, C. A. (1980). Breast milk and the risk of cytomegalovirus infection. N. Engl. J. Med., 302, 1073-1076.
288. Stagno, S., Pass, R. F., Dworsky, M. E. et al. (1982). Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N. Engl. J. Med., 306, 945-949.
289. Stagno, S., Pass, R. F., Dworsky, M. E., and Alford, C. A. (1983). Con-genital and perinatal cytomegaloviral infections. Semin. Peri-natol., 7, 31-42.
290. Stevens, D. P., Barker, L. F., Ketcham, A. S., and Meyer, H. M. (1970). Asymptomatic cytomegalovirus infection following blood transfusion in tumor surgery. J. Am. Med. Assoc., 211, 1341-1344.
291. Stoddart, C. A., Cardin, R. D., Boname, J. M., Manning, W. C., Abenes, G. B., and Mocarski, E. S. (1994). Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J. Virol., 68, 6243-6253.
292. Streblow, D. N., Soderberg-Naucler, C., Vieira, J. et al. (1999). The human cytomegalovirus chemokine receptor US28 medi-ates vascular smooth muscle cell migration. Cell., 99, 511-520.
293. Streblow, D. N., Orloff, S. L., and Nelson, J. A. (2001). Do pathogens accelerate atherosclerosisfi J. Nutrit., 131, 2798S-2804S.
294. Streblow, D. N., Kreklywich, C., Yin, Q. et al. (2003). Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants. J. Virol., 77, 2182-2194.
295. Taber, L. H., Frank, A. L., Yow, M. D., and Bagley, A. (1985). Acqui-sition of cytomegaloviral infections in families with young children: A serological study. J. Infect. Dis., 151, 948-952.
296. Taylor, P. M., Rose, M. L., Yacoub, M. H., and Pigott, R. (1992). Induc-tion of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation, 54, 451-457.
297. Taylor-Wiedeman, J., Sissons, J. G., Borysiewicz, L. K., and Sinclair, J. H. (1991). Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol.
298. Taylor-Wiedeman, J., Sissons, P., and Sinclair, J. (1994). Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers. J. Virol., 68, 1597-1604.
299. The, T. H., van der Bij, W., van den Berg, A. P. et al. (1990). Cytomegalovirus antigenemia. Rev. Infect. Dis., 12(S), 734-744.
300. Tolkoff-Rubin, N. E., Fishman, J. A., and Rubin, R. H. (2001). The bidirectional relationship between cytomegalovirus and allo-graft injury. Transpl. Proc., 33, 1773-1775.
301. Valantine, H. A., Gao, S. Z., Menon, S. G. et al. (1999). Impact of prophylactic immediate posttransplant ganciclovir on devel-opment of transplant atherosclerosis: A post hoc analysis of a randomized, placebo-controlled study. Circulation, 100, 61-66.
302. Valantine, H. A., Luikart, H., Doyle, R. et al. (2001). Impact of Cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: A comparative study of com-bined prophylaxis with CMV hyperimmune globulin plus gan-ciclovir versus ganciclovir alone. Transplantation, 72, 1647-1852.
303. Van Dam-Mieras, M. C., Bruggeman, C. A., Muller, A. D., Debie, W. H., and Zwaal, R. F. (1987). Induction of endothelial cell procoagulant activity by cytomegalovirus infection. Thromb. Res., 47, 69-75.
304. van der Bij, W., Schirm, J., Torensma, R., van Son, W. J., Tegzess, A. M., and The, T. H. (1988). Comparison between viremia and anti-genemia for detection of cytomegalovirus in blood. J. Clin. Microbiol., 26, 2531-2535.
305. Vinters, H. V., Kwok, M. K., Ho, H. W. et al. (1989). Cytomegalovirus in the nervous system of patients with the acquired immune deficiency syndrome. Brain.
306. Vochem, M., Hamprecht, K., Jahn, G., and Speer, C. P. (1998). Trans-mission of cytomegalovirus to preterm infants through breast milk. Pediatr. Infect. Dis. J., 17, 53-58.
307. Vossen, R. C., van Dam-Mieras, M. C., and Bruggeman, C. A. (1996). Cytomegalovirus infection and vessel wall pathology. Intervi-rology, 39, 213-221.
308. Waldhoer, M., Kledal, T. N., Farrell, H., and Schwartz, T. W. (2002). Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J. Virol., 76, 8161-8168.
309. Waldman, W. J. and Knight, D. A. (1996). Cytokine-mediated induc-tion of endothelial adhesion molecule and histocompatibility leukocyte antigen expression by cytomegalovirus-activated T cells. Am. J. Pathol., 148, 105-119.
310. Waldman, W. J., Roberts, W. H., Davis, D. H., Williams, M. V. Sed-mak, D. D., and Stephens, R. E. (1991). Preservation of natural endothelial cytopathogenicity of cytomegalovirus by propaga-tion in endothelial cells. Arch. Virol., 117, 143-164.
311. Waldman, W. J., Knight, D. A., Huang, E. H., and Sedmak, D. D. (1995). Bidirectional transmission of infectious cytome-galovirus between monocytes and vascular endothelial cells: An in vitro model. J. Infect. Dis., 171, 263-272.
312. Walter, E. A., Greenberg, P. D., Gilbert, M. J. et al. (1995). Reconstitu-tion of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med., 333, 1038-1044.
313. Waner, J. L., Hopkins, D. R., Weller, T. H., and Allard, E. N. (1977). Cervical excretion of cytomegalovirus: Correlation with secre-tory and humoral antibody. J. Infect. Dis., 136, 805-809.
314. Wang, D. and Shenk, T. (2005a). Human cytomegaloviruses virion protein complex required for epithelial and edothelial cell tropism. Proc. Nat. Acad. Sci. USA, 102, 18153-18158.
315. Wang, D. and Shenk T. (2005b). Human cytomegaloviruses UL131 open reading frame is required of epithelial cell tropism. J. Virol., 79, 10330-10338.
316. Weller, T. H. (1971). The cytomegaloviruses: Ubiquitous agents with protean clinical manifestations. N. Engl. J. Med., 285, 203-214.
317. Wilcox, C. M., Chalasani, N., Lazenby, A., and Schwartz, D. A. (1998). Cytomegalovirus colitis in acquired immunodeficiency syndrome: A clinical and endoscopic study. Gastrointest. Endosc., 48, 39-43.
318. Wiley, C. A. and Nelson, J. A. (1988). Role of human immunodefi-ciency virus and cytomegalovirus in AIDS encephalitis. Am. J. Pathol., 133, 73-81.
319. Williamson, W. D., Desmond, M. M., LaFevers, N., Taber, L. H., Catlin, F. I., and Weaver, T. G. (1982). Symptomatic congenital cytomegalovirus: Disorders of language, learning and hearing. Am. J. Dis. Child., 136, 902-905.
320. Williamson, W. D., Demmler, G. J., Percy, A. K., and Catlin, F. I. (1992). Progressive hearing loss in infants with asymptomatic congen-ital cytomegalovirus infection. Pediatrics, 90, 862-866.
321. Winston, D. J., Gale, R. P., Meyers, D. V. et al. (1979). Infectious com-plications of human bone marrow transplantation. Medicine, 58, 1-31.
322. Winston, D. J., Ho, W. G., Bartoni, K. et al. (1993). Ganciclovir pro-phylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann. Intern. Med., 118, 179-184.
323. Wu, T. C., Hruban, R. H., Ambinder, R. F. etal. (1992). Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am. J. Pathol., 140, 739-747.
324. Yang, Y. S., Ho, H. N., Chen, H. F. et al. (1995). Cytomegalovirus infec-tion and viral shedding in the genital tract of infertile couples. J. Med. Virol., 45, 179-182.
325. Yeager, A. S. (1975). Longitudinal, serological study of cytome-galovirus infections in nurses and in personnel without patient contact. J. Clin. Microbiol., 2, 448-450.
326. Yeager, A. S. (1983). Transmission of cytomegalovirus to mothers by infected infants: Another reason to prevent transfusion-acquired infections. Pediatr. Infect. Dis., 2, 295.
327. Yeager, A. S., Grumet, F. C., Hafieigh, E. B., Arvin, A. M., Bradley, J. S., and Prober, C. G. (1981). Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J. Pediatr., 98, 281-287.
328. Yilmaz, S., Koskinen, P. K., Kallio, E., Bruggeman, C. A., Hayry, P. J., and Lemstrom, K. B. (1996). Cytomegalovirus infection-enhanced chronic kidney allograft rejection is linked with intercellular adhesion molecule-1 expression. Kidney Int., 50, 526-537.
329. Zhou, Y. F., Leon, M. B., Waclawiw, M. A. et al. (1996). Associa-tion between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med., 335, 624-630.
330. Zhou, Y. F., Shou, M., Guetta, E. et al. (1999). Cytomegalovirus infec-tion of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation, 100, 1569-1575.
331. Zhu, H., Shen, Y., and Shenk, T. (1995). Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol., 69, 7960-7970.
332. Zhu, H., Cong, J. P., Bresnahan, W. A., and Shenk, T. E, (2002). Inhibi-tion of cyclooxygenase 2 blocks human cytomegalovirus repli-cation. Proc. Natl Acad. Sci. USA, 99, 3932-3937.
333. Zhu, J., Quyyumi, A. A., Norman, J. E., Csako, G., and Epstein, S. E. (1999). Cytomegalovirus in the pathogenesis of atherosclerosis: The role of infiammation as refiected by ele-vated C-reactive protein levels. J. Am. Coll. Cardiol., 34, 1738-1743.